ENTRY       D01276                      Drug
NAME        Atazanavir sulfate (JAN/USAN);
            Reyataz (TN)
PRODUCT     REYATAZ (E.R. Squibb & Sons)
            REYATAZ (RedPharm Drug)
  GENERIC   ATAZANAVIR (Amneal Pharmaceuticals NY LLC)
            ATAZANAVIR (Camber Pharmaceuticals)
            ATAZANAVIR (Cipla USA)
            ATAZANAVIR (Laurus Labs Limited)
            ATAZANAVIR (Zydus Lifesciences Limited)
            ATAZANAVIR (Zydus Pharmaceuticals USA)
            ATAZANAVIR SULFATE (Aurobindo Pharma Limited)
            ATAZANAVIR SULFATE (NorthStar Rx LLC)
            ATAZANAVIR SULFATE (Teva Pharmaceuticals USA)
FORMULA     C38H52N6O7. H2SO4
EXACT_MASS  802.3571
MOL_WEIGHT  802.934
CLASS       Antiviral
             DG03107  Anti-HIV agent
              DG01647  HIV protease inhibitor
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
             DG02887  UGT1A1 inhibitor
REMARK      Therapeutic category: 6250
            ATC code: J05AE08
            Chemical structure group: DG00657
            Product (DG00657): D01276<JP/US>
            Product (mixture): D10753<US>
EFFICACY    Antiviral, HIV protease inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
COMMENT     Treatment of acute and chronic HIV infection
TARGET      HIV protease [KO:K22599]
  PATHWAY   ko03230(K22599)  Viral genome structure
            ko03250(K22599)  Viral life cycle - HIV-1
INTERACTION CYP inhibition: CYP3A4 [HSA:1576]
            Enzyme inhibition: UGT1A1 [HSA:54658]
STR_MAP     map07053  Anti-HIV agents
            map07218  HIV protease inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AE Protease inhibitors
                 J05AE08 Atazanavir
                  D01276  Atazanavir sulfate (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Protease Inhibitors (PI)
               Atazanavir
                D01276  Atazanavir sulfate (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D01276  Atazanavir sulfate (JAN/USAN)
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG01647  HIV protease inhibitor
                DG00657  Atazanavir
                 D01276  Atazanavir sulfate
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00657  Atazanavir
                 D01276  Atazanavir sulfate
              DG02887  UGT1A1 inhibitor
               DG00657  Atazanavir
                D01276  Atazanavir sulfate
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D01276  Atazanavir sulfate
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                D01276  Atazanavir sulfate (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01276
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01276
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01276
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01276
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01276
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               DG01647  HIV protease inhibitor
                DG00657  Atazanavir
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                DG00657  Atazanavir
              DG02887  UGT1A1 inhibitor
               DG00657  Atazanavir
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Polyprotein cleavage inhibitor
               HIV protease inhibitor
                DG00657  Atazanavir
DBLINKS     CAS: 229975-97-7
            PubChem: 7848339
            ChEBI: 31243
            LigandBox: D01276
            NIKKAJI: J2.046.067I
ATOM        56
            1   C1b C    27.2395  -17.2356
            2   C1a C    15.6253  -19.5293
            3   O7a O    16.7868  -20.2017
            4   C7a C    17.9482  -19.5293
            5   N1b N    19.1096  -20.2017
            6   C1c C    20.2710  -19.5293
            7   C5a C    21.4324  -20.2017
            8   N1b N    22.5939  -19.5293
            9   C1c C    23.7553  -20.2017
            10  C1c C    24.9167  -19.5293
            11  C1b C    26.0781  -20.2017
            12  N1c N    27.2395  -19.5293
            13  N1b N    28.4010  -20.2017
            14  C5a C    29.5624  -19.5293
            15  C1c C    30.7238  -20.2017
            16  N1b N    31.8851  -19.5293
            17  C7a C    33.0467  -20.2017
            18  O7a O    34.2081  -19.5293
            19  C1a C    35.3695  -20.2017
            20  O6a O    17.9482  -18.1844
            21  C1d C    20.2710  -17.0353
            22  C1a C    20.3275  -15.6905
            23  O5a O    21.4324  -21.5465
            24  C1b C    23.7553  -21.5465
            25  C8y C    24.9200  -22.2189
            26  C8x C    24.9164  -23.5637
            27  C8x C    26.0810  -24.2361
            28  C8x C    27.2456  -23.5637
            29  C8x C    27.2456  -22.2189
            30  C8x C    26.0810  -21.5465
            31  O1a O    24.9167  -18.1844
            32  O5a O    29.5624  -18.1844
            33  C1d C    30.7238  -22.4923
            34  C1a C    30.7169  -23.8372
            35  O6a O    33.0467  -21.5465
            36  C1a C    21.6085  -17.0283
            37  C1a C    18.8980  -17.0426
            38  C8y C    28.4182  -16.5553
            39  C8x C    29.5595  -17.2144
            40  C8x C    30.7334  -16.5368
            41  C8y C    30.7336  -15.1814
            42  C8x C    29.5923  -14.5223
            43  C8x C    28.4184  -15.1999
            44  C8y C    31.9257  -14.4931
            45  N5x N    33.0920  -15.1666
            46  C8x C    34.2659  -14.4889
            47  C8x C    34.2660  -13.1335
            48  C8x C    33.0997  -12.4600
            49  C8x C    31.9258  -13.1376
            50  C1a C    32.0455  -22.4959
            51  C1a C    29.3347  -22.4886
            52  S4a S    16.6884  -22.8888
            53  O1d O    15.3382  -22.8888
            54  O1d O    18.0386  -22.8888
            55  O1d O    16.6829  -21.5330
            56  O1d O    16.6829  -24.2390
BOND        57
            1    21  22 1
            2     8   9 1
            3     7  23 2
            4     9  24 1 #Down
            5     9  10 1
            6    24  25 1
            7    10  11 1
            8    11  12 1
            9     2   3 1
            10   25  26 2
            11   26  27 1
            12   27  28 2
            13   28  29 1
            14   29  30 2
            15   30  25 1
            16   12  13 1
            17   10  31 1 #Up
            18   12   1 1
            19   14  32 2
            20   13  14 1
            21   15  33 1 #Up
            22    3   4 1
            23   14  15 1
            24   33  34 1
            25   15  16 1
            26   17  35 2
            27    4   5 1
            28   16  17 1
            29   17  18 1
            30    5   6 1
            31   18  19 1
            32    4  20 2
            33    6   7 1
            34    6  21 1 #Up
            35    7   8 1
            36   21  36 1
            37   21  37 1
            38    1  38 1
            39   38  39 2
            40   39  40 1
            41   40  41 2
            42   41  42 1
            43   42  43 2
            44   38  43 1
            45   41  44 1
            46   44  45 2
            47   45  46 1
            48   46  47 2
            49   47  48 1
            50   48  49 2
            51   44  49 1
            52   33  50 1
            53   33  51 1
            54   52  53 1
            55   52  54 1
            56   52  55 2
            57   52  56 2
///
